3M Company Common Stock (MMM) fair value

ACCE thesis

3M makes a broad range of industrial and consumer products, including abrasives, adhesives, tapes, respirators, safety and industrial filtration, and health care consumables, sold largely to manufacturers around the world. The business rests on a deep catalogue of materials science know-how and a large installed base of specified products, which gives it pricing power and steady demand in less cyclical categories. Revenue growth is slow at 2.5%, so the case depends on margin discipline and portfolio simplification following the separation of its healthcare and consumer units rather than on top-line acceleration. Trading at 17.5 times forward earnings against 25.9 times trailing, the market is pricing in a meaningful earnings recovery, with a 20.3% operating margin and 39.4% gross margin showing the underlying franchise is still profitable. The ROE of 81.9% is inflated by a small equity base after years of buybacks and restructuring charges, so it should be read with care, but the score of 63 out of 100 and the earnings step-up implied by the forward multiple make it worth a deeper look at the cash flow and litigation picture.